Marketscreener, stock market website
b8fab.BPYQ9T0czd3lskWB2Aexz2SLiae-15ZlhDz4wh15V8A.NZRgw2lGnbmchx22i3XbkAHRvdfyuvcS3gq3kVsAIZFbpkCGWG748NHdNg
Logo MarketScreener
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    Canada
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    TESLA, INC.
    SHELL PLC
    EXXONMOBIL HOLDINGS CORPORATION
    APPLE INC.
    T42 IOT TRACKING SOLUTIONS PLC
    NORDIC SEMICONDUCTOR
    MICROSOFT CORPORATION
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    TSX COMP
    TSX VENTURE
    S&P 500
    DOW JONES
    NASDAQ 100
    FTSE 100
    CAC 40
    DAX
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    CAD / USD
    CAD / MXN
    CAD / BRL
    CAD / EUR
    CAD / INR
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Markets
    Emerging Markets
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    Most Read News
    Key News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Interviews
    Stocks
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Interest Rates
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    USA Portfolio
    European Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Quality stocks at a reasonable price
    Undervalued stocks
    Dividend Aristocrats
    Momentum stocks
    Low capital intensity
    ESG stocks
    Investment Themes
    Homepage
    Boats
    Diabetes
    Smart City
    Pricing Power
    Gold and Silver
    Place your bets
  • Trading
    Market Timing
    Key News
    Pre/Post-Market Movers
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider transactions
  • Tools
    Dynamic Chart
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual Volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-Market Movers
    Top Fundamentals
    Fundamental Composite
    Sales Growth
    Earnings Growth
    Profitability
    Finances
    Visibility Rankings
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E
    Enterprise Value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus Composite
    Analyst Opinion
    Target Price
    Opinion Divergences
    Estimates Revisions
    Analyst Coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
Canadian Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • Canada
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • TESLA, INC.
      • SHELL PLC
      • EXXONMOBIL HOLDINGS CORPORATION
      • APPLE INC.
      • T42 IOT TRACKING SOLUTIONS PLC
      • NORDIC SEMICONDUCTOR
      • MICROSOFT CORPORATION
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • TSX COMP
      • TSX VENTURE
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • FTSE 100
      • CAC 40
      • DAX
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • CAD / USD
      • CAD / MXN
      • CAD / BRL
      • CAD / EUR
      • CAD / INR
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Markets
      • Emerging Markets
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • Most Read News
    • Key News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Interviews
    • Stocks
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Interest Rates
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • USA Portfolio
    • European Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Quality stocks at a reasonable price
      • Undervalued stocks
      • Dividend Aristocrats
      • Momentum stocks
      • Low capital intensity
      • ESG stocks
    • Investment Themes
      • Homepage
      • Boats
      • Diabetes
      • Smart City
      • Pricing Power
      • Gold and Silver
      • Place your bets
  • Trading
    • Market Timing
    • Key News
    • Pre/Post-Market Movers
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider transactions
  • Tools
    • Dynamic Chart
    • Currency Converter
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual Volumes
      • New Historical Highs
      • New Historical Lows
    • Pre/Post-Market Movers
    • Top Fundamentals
      • Fundamental Composite
      • Sales Growth
      • Earnings Growth
      • Profitability
      • Finances
      • Visibility Rankings
    • Rankings Valuation
      • Valuation Composite
      • Market Cap
      • P/E
      • Enterprise Value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus Composite
      • Analyst Opinion
      • Target Price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst Coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
Switch edition
Stock 300573 SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.
Add to a list

Shenyang Xingqi Pharmaceutical Co.,Ltd.

Stocks

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
2026-07-13
5-day change 1st Jan Change
40.79 CNY +0.49% Intraday chart for Shenyang Xingqi Pharmaceutical Co.,Ltd. -1.85% -15.86%
06-30 Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
06-28 Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. CI
Summary
Quotes
Charts
Technical Analysis Static Chart Total Return chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Insider transactions Connections
Financials
Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Calendar
Sector
Sector performance Sector dividends Financial comparisons
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial

Published on 05/30/2025 at 05:53 am EDT

MT Newswires
Add MarketScreener to your sources
Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
mtnewswires logo
© MT Newswires - 2025
Add MarketScreener to your sources
Share

Latest news about Shenyang Xingqi Pharmaceutical Co.,Ltd.

06-30 Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares. CI
06-28 Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. CI
05-24 Shenyang Xingqi Pharmaceutical Co.,Ltd. cancelled the transaction announced on May 27, 2025 CI
05-15 Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2025, Payable on 22 May 2026 CI
04-27 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-12 Shenyang Xingqi Pharmaceutical Doses First Patient in Eye Drop Trial MT
03-10 Xingqi Pharmaceutical Completes Establishment of New Subsidiary MT
01-05 Xingqi Pharmaceutical Gets Nod for Supplementary Application for Atropine Sulfate Eye Drops MT
12-08 Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue MT
25-10-28 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-09 Shenyang Xingqi Pharmaceutical Gets China Clinical Trial Nod for Macular Edema Injection MT
25-09-16 Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Interim Cash Dividend on A Shares for 2025, Payable on 24 September 2025 CI
25-08-28 Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
25-08-27 Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.
300573: Dynamic Chart

Company Profile

Logo Shenyang Xingqi Pharmaceutical Co.,Ltd.
Shenyang Xingqi Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of ophthalmic drugs. The Company's main products include drugs for delaying the progression of myopia in children, drugs for the treatment of dry eyes, ophthalmic anti-infective drugs, ophthalmic anti-inflammatory/anti-infective drugs, pupil dilatant and ciliary muscle paralyzer drugs, ophthalmic non-steroidal anti-inflammatory drugs, miotic drugs, anti-glaucoma drugs and others. The Company is also engaged in health food production, inspection and testing services, drug import and export, plastic product manufacturing, non-residential real estate leasing, machinery and equipment leasing and other businesses. The Company mainly operates its businesses in the domestic market.
Employees
2,396
Sector
Pharmaceuticals
Calendar
Earnings release - Q2 2026
More about the company

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar
Indices Europe America Asia
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

  1. Stock Market
  2. Stocks
  3. 300573 Stock
  4. News Shenyang Xingqi Pharmaceutical Co.,Ltd.
  5. Xingqi Pharmaceutical Says No Adverse Effects Seen in Phase 1 Eye Drops Trial
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
1,300,000 +members

1,300,000 +
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-6pm CET

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
Google lets you customize your preferred sources.
G GoogleChoose MarketScreener
G GoogleChoose MarketScreener

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong